SCHEMBL24754227

SCHEMBL24754227

CN(C)C(=O)c1ccc(Cn2ccc(=O)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.44
HDAC6 Q9UBN7 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.43
MGLL Q99685 1/20 0.43
EPHX2 P34913 1/20 0.41
NR1H4 Q96RI1 1/20 0.41
TBXAS1 P24557 1/20 0.40
DRD2 P14416 2/20 0.39
TBXA2R P21731 1/20 0.39
ACACB O00763 1/20 0.38
KCNH2 Q12809 1/20 0.38
MMP2 P08253 1/20 0.38
MMP9 P14780 1/20 0.38
MMP8 P22894 1/20 0.38
MAPK14 Q16539 2/20 0.37
KMT2A Q03164 1/20 0.37
HSD11B1 P28845 1/20 0.36
CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32679331 0.79 HDAC1 (0.47) HDAC1HDAC6SMN1; SMN2ALDH1A1MGLL
SCHEMBL9595456 0.75 KMT2A (0.66) SMN1; SMN2ALDH1A1HPGDMGLLKMT2A
SCHEMBL24754375 0.74 ALDH1A1 (0.44) HDAC1HDAC6SMN1; SMN2ALDH1A1HPGD
SCHEMBL24754376 0.74 BRD4 (0.41) HDAC1HDAC6SMN1; SMN2ALDH1A1HPGD
SCHEMBL23516966 0.74 ALDH1A1 (0.50) HDAC1HDAC6SMN1; SMN2ALDH1A1DRD2
SCHEMBL3274471 0.73 CA1 (0.55) SMN1; SMN2ALDH1A1HPGDEPHX2NR1H4
SCHEMBL24018194 0.73 TP53 (0.57) SMN1; SMN2ALDH1A1KMT2A
SCHEMBL1004649 0.72 ALDH1A1 (0.73) SMN1; SMN2ALDH1A1HPGDEPHX2NR1H4
SCHEMBL23517936 0.72 EP300 (0.45) HDAC1HDAC6SMN1; SMN2ALDH1A1HPGD
SCHEMBL505778 0.71 ALDH1A1 (0.55) SMN1; SMN2ALDH1A1HPGDEPHX2NR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022263829-A1 COMPOUNDS AND THEIR USE FOR THE TREATMENT OF α1-ANTITRYPSIN DEFICIENCY Z Factor Limited (GB) 2022-12-22 WO disclosed